Dahl O - Search Results

1

Late side effects and quality of life after radiotherapy for rectal cancer.

Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM. Bruheim K, et al. Among authors: dahl o. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1005-11. doi: 10.1016/j.ijrobp.2009.03.010. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540058

2

Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma?

Dahl O, Horn A, Mella O. Dahl O, et al. Acta Oncol. 1994;33(4):409-13. doi: 10.3109/02841869409098437. Acta Oncol. 1994. PMID: 8018374 Clinical Trial.

3

[Chemotherapy in colorectal cancer. Recommendations of the Norwegian Gastrointestinal Cancer Group].

Tveit KM, Dahl O, Gerner T. Tveit KM, et al. Among authors: dahl o. Tidsskr Nor Laegeforen. 1996 Jan 30;116(3):357-60. Tidsskr Nor Laegeforen. 1996. PMID: 8638262 Review. Norwegian.

4

[Treatment of fixed, primarily non-resected rectal cancer. Recommendations from Norwegian Gastrointestinal Cancer Group].

Bjerkeset T, Dahl O, Gerner T, Tveit KM. Bjerkeset T, et al. Among authors: dahl o. Tidsskr Nor Laegeforen. 1996 Jan 30;116(3):379-81. Tidsskr Nor Laegeforen. 1996. PMID: 8638268 Review. Norwegian.

5

Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.

Muren LP, Jebsen N, Gustafsson A, Dahl O. Muren LP, et al. Among authors: dahl o. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):627-37. doi: 10.1016/s0360-3016(01)01464-x. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395229

6

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.

Sørbye H, Glimelius B, Berglund A, Fokstuen T, Tveit KM, Braendengen M, Øgreid D, Dahl O. Sørbye H, et al. Among authors: dahl o. J Clin Oncol. 2004 Jan 1;22(1):31-8. doi: 10.1200/JCO.2004.05.188. J Clin Oncol. 2004. PMID: 14701765 Clinical Trial.

7

Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.

Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD. Mykletun A, et al. Among authors: dahl o, dahl aa. J Clin Oncol. 2005 May 1;23(13):3061-8. doi: 10.1200/JCO.2005.08.048. J Clin Oncol. 2005. PMID: 15860864

8

Nationwide quality assurance of rectal cancer treatment.

Wibe A, Carlsen E, Dahl O, Tveit KM, Weedon-Fekjaer H, Hestvik UE, Wiig JN; Norwegian Rectal Cancer Group. Wibe A, et al. Among authors: dahl o. Colorectal Dis. 2006 Mar;8(3):224-9. doi: 10.1111/j.1463-1318.2005.00924.x. Colorectal Dis. 2006. PMID: 16466564

9

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer.

Sørbye H, Berglund A, Tveit KM, Ogreid D, Wanderås EH, Wentzel-Larsen T, Dahl O, Glimelius B. Sørbye H, et al. Among authors: dahl o. Acta Oncol. 2007;46(7):982-8. doi: 10.1080/02841860701261568. Acta Oncol. 2007. PMID: 17917829 Clinical Trial.

10

[Radiotherapy of rectal cancer].

Balteskard L, Vonen B, Frykholm G, Dahl O, Tveit KM. Balteskard L, et al. Among authors: dahl o. Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3090-3. Tidsskr Nor Laegeforen. 2007. PMID: 18049501 Free article. Review. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page